Retinoic acid pre-treatment down regulates V. cholerae outer membrane vesicles induced acute inflammation and enhances mucosal immunity

Highlights • Cholera pentavalent outer membrane vesicles (CPMVs) induce protective immune response after two doses of oral immunization in mice model. • CPMVs induced TLR2 mediated pro-inflammatory cytokines and acute inflammation in vitro and in vivo. • Pre-treatment of All-trans retinoid acid (ATR...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2017-06, Vol.35 (28), p.3534-3547
Main Authors: Sinha, Ritam, Howlader, Debaki Ranjan, Ta, Atri, Mitra, Soma, Das, Santasabuj, Koley, Hemanta
Format: Article
Language:English
Subjects:
Adaptive immunity
Administration, Oral
Allergy and Immunology
Animals
Animals, Newborn
Antibodies, Bacterial - blood
Antigens
ATRA
Bacteria
Bacterial Outer Membrane Proteins - immunology
Bacterial Outer Membrane Proteins - toxicity
Bacterial vesicles
Children
Cholera
Cholera - immunology
Cholera - prevention & control
Cholera Vaccines - administration & dosage
Cholera Vaccines - immunology
Cholera Vaccines - toxicity
CPMVs
Cytokines - biosynthesis
Developing countries
Disease Models, Animal
Effectiveness
Female
Immune response
Immune system
Immunity
Immunity, Mucosal
Immunization
Immunogenicity, Vaccine
Immunoglobulin G - blood
Inflammation
Inflammation - prevention & control
LDCs
Malnutrition
Membrane vesicles
Membranes
Men
Metabolites
Mice
Mice, Inbred BALB C
Mucosal immunity
OMVs
Oral cavity
Pathogens
Retinoic acid
Rodents
TLR2
TLR2 protein
Toll-Like Receptor 2 - immunology
Toll-like receptors
Toxicity
Tretinoin - administration & dosage
Tretinoin - immunology
Tretinoin - pharmacology
Vaccines
Vesicles
Vibrio cholerae - immunology
Vitamin A
Waterborne diseases
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c448t-9a64c4f777fa754270147201156f6b5875f8c1a8cd3c9a0786a94dd38ddf0ca03
cites cdi_FETCH-LOGICAL-c448t-9a64c4f777fa754270147201156f6b5875f8c1a8cd3c9a0786a94dd38ddf0ca03
container_end_page 3547
container_issue 28
container_start_page 3534
container_title Vaccine
container_volume 35
creator Sinha, Ritam
Howlader, Debaki Ranjan
Ta, Atri
Mitra, Soma
Das, Santasabuj
Koley, Hemanta
description Highlights • Cholera pentavalent outer membrane vesicles (CPMVs) induce protective immune response after two doses of oral immunization in mice model. • CPMVs induced TLR2 mediated pro-inflammatory cytokines and acute inflammation in vitro and in vivo. • Pre-treatment of All-trans retinoid acid (ATRA) significantly reduces CPMVs induced TLR2 mediated pro-inflammatory cytokine response in vitro and in vivo. • Pre-treatment of ATRA induces mucosal as well as protective immune response but not systemic immune response after two doses of oral immunization with CPMVs.
doi_str_mv 10.1016/j.vaccine.2017.05.036
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1904831785</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0264410X17306606</els_id><sourcerecordid>1904831785</sourcerecordid><originalsourceid>FETCH-LOGICAL-c448t-9a64c4f777fa754270147201156f6b5875f8c1a8cd3c9a0786a94dd38ddf0ca03</originalsourceid><addsrcrecordid>eNqFktuKFDEQhhtR3HH1EZSA190m3Tn1jSLLeoAFwV3Fu5BJqt2MnWRM0iPzBL62GWbcBW-8Kgq--ov6qKZ5TnBHMOGvNt1OG-MCdD0mosOswwN_0KyIFEPbMyIfNivcc9pSgr-dNU9y3mCM2UDGx81ZLxllY09Xze_PUFyIziBtnEXbBG1JoIuHUJCNvwJK8H2ZdYGMvnbI3MYZkgYUlwIJefDrpAOgHWRn5sq4YBcDtqZVoHbTrL3XxcWAdLAIwq0OpnJ-MTHrGTnvl-DK_mnzaNJzhmenet58eXd5c_Ghvfr0_uPF26vWUCpLO2pODZ2EEJMWjPYCEyqqAML4xNdMCjZJQ7Q0djCjxkJyPVJrB2nthI3Gw3nz8pi7TfHnArmoTVxSqCsVGTGVAxGSVYodKZNizgkmtU3O67RXBKuDfrVRJ_3qoF9hpqr-OvfilL6sPdi7qb--K_DmCEC9cecgqWwcVCPWJTBF2ej-u-L1PwlmdsEZPf-APeT7a1TuFVbXhx84vAARA-Yc8-EPIkmwMg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1904831785</pqid></control><display><type>article</type><title>Retinoic acid pre-treatment down regulates V. cholerae outer membrane vesicles induced acute inflammation and enhances mucosal immunity</title><source>ScienceDirect Freedom Collection</source><creator>Sinha, Ritam ; Howlader, Debaki Ranjan ; Ta, Atri ; Mitra, Soma ; Das, Santasabuj ; Koley, Hemanta</creator><creatorcontrib>Sinha, Ritam ; Howlader, Debaki Ranjan ; Ta, Atri ; Mitra, Soma ; Das, Santasabuj ; Koley, Hemanta</creatorcontrib><description>Highlights • Cholera pentavalent outer membrane vesicles (CPMVs) induce protective immune response after two doses of oral immunization in mice model. • CPMVs induced TLR2 mediated pro-inflammatory cytokines and acute inflammation in vitro and in vivo. • Pre-treatment of All-trans retinoid acid (ATRA) significantly reduces CPMVs induced TLR2 mediated pro-inflammatory cytokine response in vitro and in vivo. • Pre-treatment of ATRA induces mucosal as well as protective immune response but not systemic immune response after two doses of oral immunization with CPMVs.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2017.05.036</identifier><identifier>PMID: 28545924</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Adaptive immunity ; Administration, Oral ; Allergy and Immunology ; Animals ; Animals, Newborn ; Antibodies, Bacterial - blood ; Antigens ; ATRA ; Bacteria ; Bacterial Outer Membrane Proteins - immunology ; Bacterial Outer Membrane Proteins - toxicity ; Bacterial vesicles ; Children ; Cholera ; Cholera - immunology ; Cholera - prevention &amp; control ; Cholera Vaccines - administration &amp; dosage ; Cholera Vaccines - immunology ; Cholera Vaccines - toxicity ; CPMVs ; Cytokines - biosynthesis ; Developing countries ; Disease Models, Animal ; Effectiveness ; Female ; Immune response ; Immune system ; Immunity ; Immunity, Mucosal ; Immunization ; Immunogenicity, Vaccine ; Immunoglobulin G - blood ; Inflammation ; Inflammation - prevention &amp; control ; LDCs ; Malnutrition ; Membrane vesicles ; Membranes ; Men ; Metabolites ; Mice ; Mice, Inbred BALB C ; Mucosal immunity ; OMVs ; Oral cavity ; Pathogens ; Retinoic acid ; Rodents ; TLR2 ; TLR2 protein ; Toll-Like Receptor 2 - immunology ; Toll-like receptors ; Toxicity ; Tretinoin - administration &amp; dosage ; Tretinoin - immunology ; Tretinoin - pharmacology ; Vaccines ; Vesicles ; Vibrio cholerae - immunology ; Vitamin A ; Waterborne diseases</subject><ispartof>Vaccine, 2017-06, Vol.35 (28), p.3534-3547</ispartof><rights>Elsevier Ltd</rights><rights>2017 Elsevier Ltd</rights><rights>Copyright © 2017 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited Jun 16, 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c448t-9a64c4f777fa754270147201156f6b5875f8c1a8cd3c9a0786a94dd38ddf0ca03</citedby><cites>FETCH-LOGICAL-c448t-9a64c4f777fa754270147201156f6b5875f8c1a8cd3c9a0786a94dd38ddf0ca03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28545924$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sinha, Ritam</creatorcontrib><creatorcontrib>Howlader, Debaki Ranjan</creatorcontrib><creatorcontrib>Ta, Atri</creatorcontrib><creatorcontrib>Mitra, Soma</creatorcontrib><creatorcontrib>Das, Santasabuj</creatorcontrib><creatorcontrib>Koley, Hemanta</creatorcontrib><title>Retinoic acid pre-treatment down regulates V. cholerae outer membrane vesicles induced acute inflammation and enhances mucosal immunity</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Highlights • Cholera pentavalent outer membrane vesicles (CPMVs) induce protective immune response after two doses of oral immunization in mice model. • CPMVs induced TLR2 mediated pro-inflammatory cytokines and acute inflammation in vitro and in vivo. • Pre-treatment of All-trans retinoid acid (ATRA) significantly reduces CPMVs induced TLR2 mediated pro-inflammatory cytokine response in vitro and in vivo. • Pre-treatment of ATRA induces mucosal as well as protective immune response but not systemic immune response after two doses of oral immunization with CPMVs.</description><subject>Adaptive immunity</subject><subject>Administration, Oral</subject><subject>Allergy and Immunology</subject><subject>Animals</subject><subject>Animals, Newborn</subject><subject>Antibodies, Bacterial - blood</subject><subject>Antigens</subject><subject>ATRA</subject><subject>Bacteria</subject><subject>Bacterial Outer Membrane Proteins - immunology</subject><subject>Bacterial Outer Membrane Proteins - toxicity</subject><subject>Bacterial vesicles</subject><subject>Children</subject><subject>Cholera</subject><subject>Cholera - immunology</subject><subject>Cholera - prevention &amp; control</subject><subject>Cholera Vaccines - administration &amp; dosage</subject><subject>Cholera Vaccines - immunology</subject><subject>Cholera Vaccines - toxicity</subject><subject>CPMVs</subject><subject>Cytokines - biosynthesis</subject><subject>Developing countries</subject><subject>Disease Models, Animal</subject><subject>Effectiveness</subject><subject>Female</subject><subject>Immune response</subject><subject>Immune system</subject><subject>Immunity</subject><subject>Immunity, Mucosal</subject><subject>Immunization</subject><subject>Immunogenicity, Vaccine</subject><subject>Immunoglobulin G - blood</subject><subject>Inflammation</subject><subject>Inflammation - prevention &amp; control</subject><subject>LDCs</subject><subject>Malnutrition</subject><subject>Membrane vesicles</subject><subject>Membranes</subject><subject>Men</subject><subject>Metabolites</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Mucosal immunity</subject><subject>OMVs</subject><subject>Oral cavity</subject><subject>Pathogens</subject><subject>Retinoic acid</subject><subject>Rodents</subject><subject>TLR2</subject><subject>TLR2 protein</subject><subject>Toll-Like Receptor 2 - immunology</subject><subject>Toll-like receptors</subject><subject>Toxicity</subject><subject>Tretinoin - administration &amp; dosage</subject><subject>Tretinoin - immunology</subject><subject>Tretinoin - pharmacology</subject><subject>Vaccines</subject><subject>Vesicles</subject><subject>Vibrio cholerae - immunology</subject><subject>Vitamin A</subject><subject>Waterborne diseases</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqFktuKFDEQhhtR3HH1EZSA190m3Tn1jSLLeoAFwV3Fu5BJqt2MnWRM0iPzBL62GWbcBW-8Kgq--ov6qKZ5TnBHMOGvNt1OG-MCdD0mosOswwN_0KyIFEPbMyIfNivcc9pSgr-dNU9y3mCM2UDGx81ZLxllY09Xze_PUFyIziBtnEXbBG1JoIuHUJCNvwJK8H2ZdYGMvnbI3MYZkgYUlwIJefDrpAOgHWRn5sq4YBcDtqZVoHbTrL3XxcWAdLAIwq0OpnJ-MTHrGTnvl-DK_mnzaNJzhmenet58eXd5c_Ghvfr0_uPF26vWUCpLO2pODZ2EEJMWjPYCEyqqAML4xNdMCjZJQ7Q0djCjxkJyPVJrB2nthI3Gw3nz8pi7TfHnArmoTVxSqCsVGTGVAxGSVYodKZNizgkmtU3O67RXBKuDfrVRJ_3qoF9hpqr-OvfilL6sPdi7qb--K_DmCEC9cecgqWwcVCPWJTBF2ej-u-L1PwlmdsEZPf-APeT7a1TuFVbXhx84vAARA-Yc8-EPIkmwMg</recordid><startdate>20170616</startdate><enddate>20170616</enddate><creator>Sinha, Ritam</creator><creator>Howlader, Debaki Ranjan</creator><creator>Ta, Atri</creator><creator>Mitra, Soma</creator><creator>Das, Santasabuj</creator><creator>Koley, Hemanta</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope></search><sort><creationdate>20170616</creationdate><title>Retinoic acid pre-treatment down regulates V. cholerae outer membrane vesicles induced acute inflammation and enhances mucosal immunity</title><author>Sinha, Ritam ; Howlader, Debaki Ranjan ; Ta, Atri ; Mitra, Soma ; Das, Santasabuj ; Koley, Hemanta</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c448t-9a64c4f777fa754270147201156f6b5875f8c1a8cd3c9a0786a94dd38ddf0ca03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adaptive immunity</topic><topic>Administration, Oral</topic><topic>Allergy and Immunology</topic><topic>Animals</topic><topic>Animals, Newborn</topic><topic>Antibodies, Bacterial - blood</topic><topic>Antigens</topic><topic>ATRA</topic><topic>Bacteria</topic><topic>Bacterial Outer Membrane Proteins - immunology</topic><topic>Bacterial Outer Membrane Proteins - toxicity</topic><topic>Bacterial vesicles</topic><topic>Children</topic><topic>Cholera</topic><topic>Cholera - immunology</topic><topic>Cholera - prevention &amp; control</topic><topic>Cholera Vaccines - administration &amp; dosage</topic><topic>Cholera Vaccines - immunology</topic><topic>Cholera Vaccines - toxicity</topic><topic>CPMVs</topic><topic>Cytokines - biosynthesis</topic><topic>Developing countries</topic><topic>Disease Models, Animal</topic><topic>Effectiveness</topic><topic>Female</topic><topic>Immune response</topic><topic>Immune system</topic><topic>Immunity</topic><topic>Immunity, Mucosal</topic><topic>Immunization</topic><topic>Immunogenicity, Vaccine</topic><topic>Immunoglobulin G - blood</topic><topic>Inflammation</topic><topic>Inflammation - prevention &amp; control</topic><topic>LDCs</topic><topic>Malnutrition</topic><topic>Membrane vesicles</topic><topic>Membranes</topic><topic>Men</topic><topic>Metabolites</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Mucosal immunity</topic><topic>OMVs</topic><topic>Oral cavity</topic><topic>Pathogens</topic><topic>Retinoic acid</topic><topic>Rodents</topic><topic>TLR2</topic><topic>TLR2 protein</topic><topic>Toll-Like Receptor 2 - immunology</topic><topic>Toll-like receptors</topic><topic>Toxicity</topic><topic>Tretinoin - administration &amp; dosage</topic><topic>Tretinoin - immunology</topic><topic>Tretinoin - pharmacology</topic><topic>Vaccines</topic><topic>Vesicles</topic><topic>Vibrio cholerae - immunology</topic><topic>Vitamin A</topic><topic>Waterborne diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sinha, Ritam</creatorcontrib><creatorcontrib>Howlader, Debaki Ranjan</creatorcontrib><creatorcontrib>Ta, Atri</creatorcontrib><creatorcontrib>Mitra, Soma</creatorcontrib><creatorcontrib>Das, Santasabuj</creatorcontrib><creatorcontrib>Koley, Hemanta</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sinha, Ritam</au><au>Howlader, Debaki Ranjan</au><au>Ta, Atri</au><au>Mitra, Soma</au><au>Das, Santasabuj</au><au>Koley, Hemanta</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Retinoic acid pre-treatment down regulates V. cholerae outer membrane vesicles induced acute inflammation and enhances mucosal immunity</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2017-06-16</date><risdate>2017</risdate><volume>35</volume><issue>28</issue><spage>3534</spage><epage>3547</epage><pages>3534-3547</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><abstract>Highlights • Cholera pentavalent outer membrane vesicles (CPMVs) induce protective immune response after two doses of oral immunization in mice model. • CPMVs induced TLR2 mediated pro-inflammatory cytokines and acute inflammation in vitro and in vivo. • Pre-treatment of All-trans retinoid acid (ATRA) significantly reduces CPMVs induced TLR2 mediated pro-inflammatory cytokine response in vitro and in vivo. • Pre-treatment of ATRA induces mucosal as well as protective immune response but not systemic immune response after two doses of oral immunization with CPMVs.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>28545924</pmid><doi>10.1016/j.vaccine.2017.05.036</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0264-410X
ispartof Vaccine, 2017-06, Vol.35 (28), p.3534-3547
issn 0264-410X
1873-2518
language eng
recordid cdi_proquest_journals_1904831785
source ScienceDirect Freedom Collection
subjects Adaptive immunity
Administration, Oral
Allergy and Immunology
Animals
Animals, Newborn
Antibodies, Bacterial - blood
Antigens
ATRA
Bacteria
Bacterial Outer Membrane Proteins - immunology
Bacterial Outer Membrane Proteins - toxicity
Bacterial vesicles
Children
Cholera
Cholera - immunology
Cholera - prevention & control
Cholera Vaccines - administration & dosage
Cholera Vaccines - immunology
Cholera Vaccines - toxicity
CPMVs
Cytokines - biosynthesis
Developing countries
Disease Models, Animal
Effectiveness
Female
Immune response
Immune system
Immunity
Immunity, Mucosal
Immunization
Immunogenicity, Vaccine
Immunoglobulin G - blood
Inflammation
Inflammation - prevention & control
LDCs
Malnutrition
Membrane vesicles
Membranes
Men
Metabolites
Mice
Mice, Inbred BALB C
Mucosal immunity
OMVs
Oral cavity
Pathogens
Retinoic acid
Rodents
TLR2
TLR2 protein
Toll-Like Receptor 2 - immunology
Toll-like receptors
Toxicity
Tretinoin - administration & dosage
Tretinoin - immunology
Tretinoin - pharmacology
Vaccines
Vesicles
Vibrio cholerae - immunology
Vitamin A
Waterborne diseases
title Retinoic acid pre-treatment down regulates V. cholerae outer membrane vesicles induced acute inflammation and enhances mucosal immunity
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T23%3A05%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Retinoic%20acid%20pre-treatment%20down%20regulates%20V.%20cholerae%20outer%20membrane%20vesicles%20induced%20acute%20inflammation%20and%20enhances%20mucosal%20immunity&rft.jtitle=Vaccine&rft.au=Sinha,%20Ritam&rft.date=2017-06-16&rft.volume=35&rft.issue=28&rft.spage=3534&rft.epage=3547&rft.pages=3534-3547&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2017.05.036&rft_dat=%3Cproquest_cross%3E1904831785%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c448t-9a64c4f777fa754270147201156f6b5875f8c1a8cd3c9a0786a94dd38ddf0ca03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1904831785&rft_id=info:pmid/28545924&rfr_iscdi=true